Article
A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-beta signals.
FEBS letters - 3 Jul 1998
Goto D, Yagi K, Inoue H, Iwamoto I, Kawabata M, Miyazono K, Kato M
Abstract excerpt
A missense mutation of Smad2 identified in cancer cells was reconstructed on the corresponding residue of Smad3. This mutant, Smad3D407E, was not phosphorylated by the constitutively active form of type I receptor for transforming growth factor-beta (TGF-beta), and inhibited the phosphorylation o...
Topics
- Amino Acid Sequence
- Animals
- Bone Morphogenetic Protein Receptors, Type I
- COS Cells
- Cell Line
- DNA-Binding Proteins
- Keratinocytes
- Molecular Sequence Data
- Mutation
- Phosphorylation
- Protein Serine-Threonine Kinases
- Receptors, Growth Factor
- Recombinant Fusion Proteins
- Signal Transduction